Capabilities
Active Pharmaceutical Ingredients
Product
Facilities
Finished Dose Formulations
Product
Facilities
Antimicrobial Solutions
Novel Medicine
Featured Portfolio
Antimicrobial Stewardship Program
Exblifep
Research
Fighting AMR
Fighting AMR
Antimicrobial Stewardships
Company
About us
Careers
Our thoughts
Investor
Contact
Contact
Stockexchanges
Intimation_Purchase of Assets
July 31, 2025
Intimation_Acquisition of Foreign Wholly Owned Subsidiary
July 31, 2025
Integrated Governance Report_June 30, 2025
July 29, 2025
Reconciliation of Share Capital_June 30, 2025
July 26, 2025
Intimation under Reg 30_Deed of Hypothecation
July 17, 2025
Certificate under Reg 74(5) of DP Regulation_June 30, 2025
July 14, 2025
Intimation of 2nd Motion Petition
July 10, 2025
Intimation under Reg 30_Reappointment of IDs
June 30, 2025
Trading Window Closure_June, 2025
June 27, 2025
Intimation of Record Date
June 9, 2025
Intimation under Reg 30_NCLT_Order
June 6, 2025
Intimation under Reg 30_Corporate Guarantee
June 3, 2025
Intimation on receipt of EIR after the USFDA Inspection
May 29, 2025
Comments of Board submitted with SEs
May 28, 2025
Newspaper Publication_Notice of NCLT Convened Meeting of Members and Creditors
May 26, 2025
Outcome of BM_May 26, 2025
May 26, 2025
Previous
1
...
Next
3 / 36